Provided by Tiger Trade Technology Pte. Ltd.

Immunic, Inc.

6.96
-0.9950-12.52%
Volume:359.01K
Turnover:2.59M
Market Cap:94.59M
PE:-1.74
High:8.14
Open:7.96
Low:6.93
Close:7.95
52wk High:17.43
52wk Low:5.06
Shares:13.60M
Float Shares:12.01M
Volume Ratio:1.11
T/O Rate:2.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9979
EPS(LYR):-6.2414
ROE:-138.17%
ROA:-66.80%
PB:0.74
PE(LYR):-1.11

Loading ...

Immunic Grants Inducement Stock Options for 12,900 Shares to Three New Employees Under 2026 Plan

Reuters
·
Yesterday

Immunic Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Yesterday

Immunic Reports Calliper Extension Data Showing Sustained Disability Outcomes for Vidofludimus Calcium in Progressive MS Through Week 48

Reuters
·
Oct 07

Eqs-News: Immunic to Present New Clinical, Biomarker and Preclinical Data on Vidofludimus Calcium at Mstoronto2026 – the 10TH Joint Actrims-Ectrims Meeting

THOMSON REUTERS
·
Oct 07

We Think Immunic (NASDAQ:IMUX) Needs To Drive Business Growth Carefully

Simply Wall St.
·
Oct 05

Immunic Grants Options for 196,350 Shares to Seven New Hires Under Inducement Equity Plan

Reuters
·
Sep 30

Immunic Director Duane Nash Resigns, Board Shrinks to Nine Members

Reuters
·
Sep 12

Leerink Partners Sticks to Its Buy Rating for Immunic (IMUX)

TIPRANKS
·
Sep 10

Analysts Are Bullish on These Healthcare Stocks: Immunic (IMUX), Celldex (CLDX)

TIPRANKS
·
Sep 10

Immunic Price Target Maintained with a $22.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 10

Immunic Highlights Multiple Sclerosis Program in R&D Webinar

TIPRANKS
·
Sep 09

Immunic Posts Investor Overview Presentation on Multiple Sclerosis Strategy

Reuters
·
Sep 04

Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day

Reuters
·
Sep 02

Analyst Reiterates Buy on Immunic, Sees Undervalued MS Opportunity with Unchanged $56 Price Target

TIPRANKS
·
Sep 02

Roth Capital Partners Adjusts Price Target on Immunic to $29 From $19, Maintains Buy Rating

MT Newswires Live
·
Sep 01

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Incyte (INCY) and Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 01

Immunic price target raised to $29 from $19 at Roth Capital

TIPRANKS
·
Sep 01

Immunic Appoints Chitrang Davé as Chief Data and Digital Officer

Reuters
·
Sep 01

Immunic Appoints Chitrang DavÉ as Chief Data and Digital Officer

THOMSON REUTERS
·
Sep 01

Immunic initiated with an Outperform at Wedbush

TIPRANKS
·
Aug 17